Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes

被引:14
作者
de Lemos, James A.
Morrow, David A.
机构
[1] Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA
[2] Brigham & Womens Hosp, TIMI Study Grp, Cardiovasc Div, Boston, MA 02115 USA
关键词
D O I
10.1016/j.ahj.2007.02.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:450 / 453
页数:4
相关论文
共 19 条
[1]   Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes [J].
Bazzino, O ;
Fuselli, JJ ;
Botto, F ;
de Arenaza, DP ;
Bahit, C ;
Dadone, J .
EUROPEAN HEART JOURNAL, 2004, 25 (10) :859-866
[2]   Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. [J].
Cannon, CP ;
Weintraub, WS ;
Demopoulos, LA ;
Vicari, R ;
Frey, MJ ;
Lakkis, N ;
Neumann, FJ ;
Robertson, DH ;
DeLucca, PT ;
DiBattiste, PM ;
Gibson, CM ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1879-1887
[3]   The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [J].
de Lemos, JA ;
Morrow, DA ;
Bentley, JH ;
Omland, T ;
Sabatine, MS ;
McCabe, CH ;
Hall, C ;
Cannon, CP ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1014-1021
[4]   N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes [J].
Galvani, M ;
Ottani, F ;
Oltrona, L ;
Ardissino, D ;
Gensini, GF ;
Maggioni, AP ;
Mannucci, PM ;
Mininni, N ;
Prando, MD ;
Tubaro, M ;
Vernocchi, A ;
Vecchio, C .
CIRCULATION, 2004, 110 (02) :128-134
[5]   N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease -: A Global Utilization of Strategies to Open occluded arteries (GUSTO)-IV substudy [J].
James, SK ;
Lindahl, B ;
Siegbahn, A ;
Stridsberg, M ;
Venge, P ;
Armstrong, P ;
Barnathan, ES ;
Califf, R ;
Topol, EJ ;
Simoons, ML ;
Wallentin, L .
CIRCULATION, 2003, 108 (03) :275-281
[6]   Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes -: A GUSTO-IV substudy [J].
James, Stefan K. ;
Lindback, Johan ;
Tilly, Johanna ;
Siegbahn, Agneta ;
Venge, Per ;
Armstrong, Paul ;
Calif, Robert ;
Simoons, Maarten L. ;
Wallentin, Lars ;
Lindahl, Bertil .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (06) :1146-1154
[7]   N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease [J].
Jernberg, T ;
Lindahl, B ;
Siegbahn, A ;
Andren, B ;
Frostfeldt, G ;
Lagerqvist, B ;
Stridsberg, M ;
Venge, P ;
Wallentin, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (11) :1909-1916
[8]   N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease [J].
Kragelund, C ;
Gronning, B ;
Kober, L ;
Hildebrandt, P ;
Steffensen, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (07) :666-675
[9]   Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarttion - B-Type natriuretic peptide and prognosis in TACTICS-TIMI 18 [J].
Morrow, DA ;
de Lemos, JA ;
Sabatine, MS ;
Murphy, SA ;
Demopoulos, LA ;
DiBattiste, PM ;
McCabe, CH ;
Gibson, CM ;
Cannon, CP ;
Braunwald, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (08) :1264-1272
[10]   Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease [J].
Morrow, DA ;
de Lemos, JA ;
Blazing, MA ;
Sabatine, MS ;
Murphy, SA ;
Jarolim, P ;
White, HD ;
Fox, KAA ;
Califf, RM ;
Braunwald, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (22) :2866-2871